Multiplexing Spheroid Volume, Resazurin and Acid Phosphatase Viability Assays for High-Throughput Screening of Tumour Spheroids and Stem Cell Neurospheres

por Ivanov, Delyan P., Parker, Terry L., Walker, David A., Alexander, Cameron, Ashford, Marianne B., Gellert, Paul R., Garnett, Martin C.
Publicado 2014

Critical considerations for targeting colorectal liver metastases with nanotechnology

por Arshad, Usman, Sutton, Paul A., Ashford, Marianne B., Treacher, Kevin E., Liptrott, Neill J., Rannard, Steve P., Goldring, Christopher E., Owen, Andrew
Publicado 2019

High-resolution 3D visualization of nanomedicine distribution in tumors

por Moss, Jennifer I., Barjat, Hervé, Emmas, Sally-Ann, Strittmatter, Nicole, Maynard, Juliana, Goodwin, Richard J. A., Storm, Gert, Lammers, Twan, Puri, Sanyogitta, Ashford, Marianne B., Barry, Simon T.
Publicado 2020

Assessing Lymphatic Uptake of Lipids Using Magnetic Resonance Imaging: A Feasibility Study in Healthy Human Volunteers with Potential Application for Tracking Lymph Node Delivery o...

por Jewell, Adelaide, Williams, Hannah, Hoad, Caroline L., Gellert, Paul R., Ashford, Marianne B., Butler, James, Stolnik, Snow, Scurr, David, Stocks, Michael J., Marciani, Luca, Gowland, Penny A., Gershkovich, Pavel
Publicado 2021

Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution

por Strittmatter, Nicole, Moss, Jennifer I., Race, Alan M., Sutton, Daniel, Canales, Jaime Rodriguez, Ling, Stephanie, Wong, Edmond, Wilson, Joanne, Smith, Aaron, Howes, Colin, Bunch, Josephine, Barry, Simon T., Goodwin, Richard J.A., Ashford, Marianne B.
Publicado 2022

In search of effective therapies to overcome resistance to Temozolomide in brain tumours

por Bouzinab, Kaouthar, Summers, Helen, Zhang, Jihong, Stevens, Malcolm F. G., Moody, Christopher J., Turyanska, Lyudmila, Thomas, Neil R., Gershkovich, Pavel, Ashford, Marianne B., Vitterso, Emily, Storer, Lisa C. D., Grundy, Richard, Bradshaw, Tracey D.
Publicado 2019

Design and optimisation of dendrimer-conjugated Bcl-2/x(L) inhibitor, AZD0466, with improved therapeutic index for cancer therapy

por Patterson, Claire M., Balachander, Srividya B., Grant, Iain, Pop-Damkov, Petar, Kelly, Brian, McCoull, William, Parker, Jeremy, Giannis, Michael, Hill, Kathryn J., Gibbons, Francis D., Hennessy, Edward J., Kemmitt, Paul, Harmer, Alexander R., Gales, Sonya, Purbrick, Stuart, Redmond, Sean, Skinner, Matthew, Graham, Lorraine, Secrist, J. Paul, Schuller, Alwin G., Wen, Shenghua, Adam, Ammar, Reimer, Corinne, Cidado, Justin, Wild, Martin, Gangl, Eric, Fawell, Stephen E., Saeh, Jamal, Davies, Barry R., Owen, David J., Ashford, Marianne B.
Publicado 2021